Cure­Vac gains COO and hands Flo­ri­an von der Mülbe new as­sign­ment in the midst of Covid-19 vac­cine trou­bles; As Ken Fra­zier re­tires, Mer­ck hires chief strat­e­gy of­fi­cer

→ Aim­ing to bounce back and try­ing to ac­cen­tu­ate the pos­i­tive af­ter its mR­NA Covid-19 vac­cine took a ma­jor prat­fall, Cure­Vac is shak­ing things up by bring­ing in Malte Gre­une as COO and giv­ing new re­spon­si­bil­i­ties to co-founder and chief pro­duc­tion of­fi­cer Flo­ri­an von der Mülbe. Gre­une jumps on board from Sanofi af­ter a near­ly 10-year run where he was sta­tioned in Ger­many and spent the last sev­er­al months as gen­er­al man­ag­er and VP, car­tridges, de­vices & in­sulin tech­nol­o­gy group in Frank­furt.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER